NGEN:CC

Quote

Short

News

Articles

Message Board

NervGen Pharma Corp. (TSXVC : NGEN:CC ) News

NervGen Pharma Corp. (TSXVC: NGEN:CC) News Releases

NGEN:CC News Releases

May 26, 2026 07:15:00 am

NGEN:CC : TSXVC

GlobeNewswire

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study

May 21, 2026 11:27:00 pm

NGEN:CC : TSXVC

GlobeNewswire

NervGen Announces Pricing of US$60.0 Million Public Offering of Securities

May 21, 2026 04:01:00 pm

NGEN:CC : TSXVC

GlobeNewswire

NervGen Announces Proposed Public Offering of Securities

May 18, 2026 07:15:00 am

NGEN:CC : TSXVC

GlobeNewswire

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

April 27, 2026 07:30:00 am

NGEN:CC : TSXVC

GlobeNewswire

NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer

April 13, 2026 07:45:00 am

NGEN:CC : TSXVC

GlobeNewswire

NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference

April 07, 2026 07:30:00 am

NGEN:CC : TSXVC

GlobeNewswire

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

March 31, 2026 07:45:00 am

NGEN:CC : TSXVC

GlobeNewswire

NervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates

March 17, 2026 12:19:37 pm

NGEN:CC : TSXVC

SeekingAlpha

NervGen Pharma: I See Promise, But The Clock Is Ticking (Rating Downgrade)

March 16, 2026 07:00:28 am

NGEN:CC : TSXVC

Canadian Earnings Reports

Expected Canadian Company Earnings on Monday, March 16th, 2026

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account